A recent study identified CA-074Me as a specific cell-permeable CTSB inhibitor [50] and small-molecule inhibitor diethyl-pythiDC that targets P4HA1 has been used for treating colorectal cancer [51]. Here, CTSB is linked to colorectal cancer.